European Inactivated vaccines Market Research Report

The European inactivated animal vaccine market, mainly driven by the growing prevalence of animal diseases and increasing incidences of zoonotic diseases in humans, was valued at $744 million in 2013, and is projected to reach $1,026 million by 2018, at a CAGR of 6.6% during the period, 2013 to 2018.

The market report analyzes the market in terms of 6 products, namely, aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The major types of this market include preventive and therapeutic. All these products are expected to experience a positive growth till 2018. Some important examples of inactivated vaccines are Nobivac rabies vaccine, Biomune Avian Polyomavirus Vaccine, Nobilis COR4+IB+ND+EDS, Nobilis Corvac, and Nobilis Coryza.

Europe is the largest & fastest-growing market, globally. This high share is attributed to its highly organized livestock farms and the huge demand for livestock products, such as food (meat, egg, milk, and its byproducts) and non-food items from the European population.

The report also provides an extensive competitive landscaping of the leading companies operating in this market. The main companies include Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac. Furthermore, the segment and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.

Customization Options

Along with the market data, customize the MMM assessments to meet your company’s specific needs. Customize to get a comprehensive summary of the industry standards and a deep-dive analysis of the following parameters:

Product Analysis:

• Usage pattern (in-depth trend analysis) of products (segment-wise)
• Product matrix, which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
• End-user adoption rate analysis of the products (segment and country-wise)
• A comprehensive coverage of product approvals, pipeline products, and product recalls

Epidemiology Data:

• Country-specific prevalence of infectious Coryza, infectious bronchitis, Gumboro disease, Newcastle disease, foot & mouth diseases
•  Country-specific patient infectious Coryza, infectious Bronchitis, Gumboro disease, Newcastle disease, foot & mouth diseases
• Disease progression (pattern analysis)

Surgeons/Physicians Perception Matrix:

• Fast turn-around analysis of surgeons’ responses to market events and trends
• Pattern analysis of usage of inactivated vaccines by physicians
• Surgeons’ opinions about products from different companies
• Surgeons’ qualitative inputs on epidemiology data

Brand/Product Perception Matrix:

• A comprehensive study of customers’ perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
• An analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)

Competitive Intelligence:

• The company share analysis of the top players of the market in the region
• The crucial developments and strategies that companies inculcate in their portfolio

Alternative Products: Impact analysis

MMM’s Healthcare Decision Making Quadrant: It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters such as patient dynamics (patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and macroeconomic indicators (number of hospitals and clinics, diagnosis rate, treatment rate and healthcare expenditure)

Please fill in the form below to receive a free copy of the Summary of this Report

* First Name :

* Last Name :

* Designation :

* Company :

* Email(Username) :

* Phone :

* Country :

-- Select Country -- India Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antigua Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia Herzegovina Botswana Brazil British Virgin Island Brunei Darussalam Bulgaria Burkina Faso Burundi Cote d'Ivoire Cambodia Cameroon Canada Cape Verde Cayman Isls Central African Republic Chad Chile China Colombia Comoros Congo Cook Island Costa Rica Croatia Cuba Cyprus Czech Republic Democratic People's Republic of Korea Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Faroe Islands Falkland Islands (Malvinas) Fiji Finl France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenl Grenada Guadeloupe Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Holy See Honduras Hong Kong Special Administrative Hungary Iceland Indonesia Iran (Islamic Republic of Iran) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Special Administrative Region of China Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia, Federated States of Micronesia Monaco Mongolia Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherland Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Islands Northern Mariana Islands Norway Occupied Palestinian Territory Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Republic of Korea Republic of Moldova Romania Russian Federation Rwa Saint Helena Saint Kitts Nevis Saint Lucia Saint Pierre Miquelon Saint Vincent the Grenadines Samoa San Marino Sao Tome Principe Saudi Arabia Senegal Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa Spain Sri Lanka Sudan Suriname Svalbard Jan Mayen Islands Swazil Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Thailand The former Yugoslav Republic of Macedonia Timor-Leste Togo Tokelau Tonga Trinidad Tobago Tunisia Turkey Turkmenistan Turks Caicos Isls Tuvalu Uga Ukraine United Arab Emirates United Kingdom United Republic of Tanzania United States United States Virgin Isls Uruguay Uzbekistan Vanuatu Venezuela Viet Nam Wallis Futuna Isls Western Sahara Yemen Yugoslavia Zambia Zimbabwe

Comments :

Reports Interested in :European Inactivated vaccines Market Research Report

* Enter the text from the image to the text box :